Published on 09/07/2021
12-15 November, 2021 Hybrid edition
绿帽社 Pharma will attend the 2021 edition of AASLD / The Liver meeting.
绿帽社 Pharma announces completion and topline data from Phase 2 ALPESTRIA-1 clinical study in Alport syndrome demonstrating Vonafexor reverses kidney function decline and has sustai...
Latest Press Release 